Related Experiment Video
Updated: May 16, 2026
Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice
Published on: July 11, 2025
Proteomic analysis of alterations induced by perinatal hypoxic-ischemic brain injury
Katja Rosenkranz1, Caroline May, Carola Meier
1Department of Functional Proteomics, Ruhr-University Bochum, Germany. Katja.Rosenkranz@rub.de
Insights
Perinatal hypoxic-ischemic brain injury impacts neonatal rats, altering protein expression. Researchers identified key proteins like Calcineurin A, revealing mechanisms for potential new therapies.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Perinatal hypoxic-ischemic brain injury is a major cause of infant neurological deficits.
- Current therapeutic strategies for this condition are limited, necessitating new treatment approaches.
- Understanding the underlying molecular mechanisms is crucial for developing innovative therapies.
Purpose of the Study:
- To identify proteins affected by perinatal hypoxic-ischemic brain injury in neonatal rats.
- To elucidate the molecular pathways involved in brain damage following hypoxia-ischemia.
Main Methods:
- Proteomic analysis using 2D-DIGE to compare protein expression in lesioned and non-lesioned hemispheres.
- Western Blot analysis to validate changes in specific protein expression, including Calcineurin A.
- Assays to investigate protein modifications like proteolysis and dephosphorylation.
Main Results:
- Proteome analysis identified altered expression of Calcineurin A, Coronin-1A, and GFAP in the injured brain hemispheres.
- Calcineurin A showed increased expression and was found in truncated forms due to calpain-mediated proteolysis.
- Active Calcineurin was linked to the dephosphorylation of Darpp-32 in the lesioned hemispheres.
Conclusions:
- Perinatal hypoxic-ischemic brain injury induces significant changes in protein expression and modification.
- Calcineurin A, affected by calpain activity, plays a role in the molecular cascade following brain injury.
- These findings provide insights into the mechanisms of brain damage and potential therapeutic targets.
Abstract:
Perinatal hypoxic-ischemic brain injury is an important cause of neurological deficits still causing mortality and morbidity in the early period of life. As efficient clinical or pharmaceutical strategies to prevent or reduce the outcome of perinatal hypoxic-ischemic brain damage are limited, the development of new therapies is of utmost importance. To evolve innovative therapeutic concepts, elucidation of the mechanisms contributing to the neurological impairments upon hypoxic-ischemic brain injury is necessary. Therefore, we aimed for the identification of proteins that are affected by hypoxic-ischemic brain injury in neonatal rats. To assess changes in protein expression two days after induction of brain damage, a 2D-DIGE based proteome analysis was performed. Among the proteins altered after hypoxic-ischemic brain injury, Calcineurin A, Coronin-1A, as well as GFAP were identified, showing higher expression in lesioned hemispheres. Validation of the changes in Calcineurin A expression by Western Blot analysis demonstrated several truncated forms of this protein generated by limited proteolysis after hypoxia-ischemia. Further analysis revealed activation of calpain, which is involved in the limited proteolysis of Calcineurin. Active forms of Calcineurin are associated with the dephosphorylation of Darpp-32, an effect that was also demonstrated in lesioned hemispheres after perinatal brain injury.
